A biomimetic nanocomposite with enzyme-like activities and CXCR4 antagonism efficiently enhances the therapeutic efficacy of acute myeloid leukemia

Despite the progress made to improve therapeutic outcomes for acute myeloid leukemia (AML), many unmet clinical needs remain to be resolved. Unlike existing anti-AML strategies, here we developed a biomimetic nanocomposite to efficiently eliminate the leukemia cells in the bone marrow and prevent th...

Descripción completa

Detalles Bibliográficos
Autores principales: Kong, Fei, He, Hongliang, Bai, Huiyuan, Yang, Fang, Ma, Ming, Gu, Ning, Zhang, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: KeAi Publishing 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8976099/
https://www.ncbi.nlm.nih.gov/pubmed/35415298
http://dx.doi.org/10.1016/j.bioactmat.2022.03.022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8976099/
https://www.ncbi.nlm.nih.gov/pubmed/35415298
http://dx.doi.org/10.1016/j.bioactmat.2022.03.022

Ejemplares similares